The NCI recently awarded more than $7.9 million to support a new Radiation Oncology-Biology Integration Network (ROBIN) center at Winship Cancer Institute of Emory University and the Cleveland Clinic.
Exelixis Announces Results from Phase 2 Trial of Cabozantinib in Combination with Pembrolizumab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma at ASCO 2022
Exelixis Announces Results from Phase 2 Trial of Cabozantinib in Combination with Pembrolizumab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma at ASCO 2022 - read this article along with other careers information, tips and advice on BioSpace
A recent event celebrated faculty who had earned promotion and/or the grant of tenure, were appointed to named and endowed professorships or had earned membership in the National Academies or the American Academy of Arts and Sciences.
CRI Immunotherapy Summit Grows Along with Cancer Treatment Prospects pressreleasepoint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressreleasepoint.com Daily Mail and Mail on Sunday newspapers.